Ymmuno Biotech

Brazil
Florianópolis, Santa Catarina, Brazil

Company profile

Ymmuno Biotech company profile

A Biotech start-up focused on developing new science-based products. Immunotherapies and Orally passive immunization is our cup of tea. Nowadays we are working on a new therapy to improve life quality in Crohn´s Disease patients and improving a new methodology to reduce the use of antibiotics in hospitalized elderly patients.

Business identity

Contact email
[email protected]
Phone number
+5548999187299
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2019-02-05

Headquarters

Country code
BR
Continent
South America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$11,065
Last funding
Seed / $11,065 / 2020-08-14
Last equity funding
Seed / $11,065
Investors
1
Founders
2

Founders and investors

Founders

Itamar Durli JuniorJhonatan Macedo Ribeiro

Investors

FAPESC - Fundação de Amparo à Pesquisa e Inovação